Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effet indésirable rare d’un anti-IL-1RA.
Brevet P, Curie A, Princivil C, Zarnitsky C, Boulay C, Alcaix D. Brevet P, et al. Rev Med Interne. 2020 May;41(5):343-345. doi: 10.1016/j.revmed.2019.11.008. Epub 2019 Dec 6. Rev Med Interne. 2020. PMID: 31818504 French.
Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatism.
Hagege O, Brevet P, Gerard B, Duhamel E, Mihailescu SD, Alcaix D, Weber AJ, Marcelli C, Grosjean J, Varin R, Lequerré T, Vittecoq O. Hagege O, et al. Among authors: brevet p. Clin Exp Rheumatol. 2024 Sep 17. doi: 10.55563/clinexprheumatol/6cxcaq. Online ahead of print. Clin Exp Rheumatol. 2024. PMID: 39360371
Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing In Vivo Epitopes of Its γ Chain One of Which Is Not Cross Reactive With Anti-Citrullinated Protein Antibodies.
Brevet P, Lattard C, Guillou C, Rottenberg P, Fardellone P, Le-Loët X, Lequerré T, Cosette P, Boyer O, Fréret M, Vittecoq O. Brevet P, et al. Front Immunol. 2021 Oct 7;12:733511. doi: 10.3389/fimmu.2021.733511. eCollection 2021. Front Immunol. 2021. PMID: 34691039 Free PMC article.
Potential efficacy of T and B lymphocyte-targeted therapies on articular involvement of patients with rheumatoid arthritis and systemic sclerosis overlap syndrome. Results from a 2-centre series of 19 cases.
Lebel N, Marie I, Grosjean J, Brevet P, Leclercq M, Dumont A, Levesque H, Benhamou Y, Marcelli C, Lequerre T, Vittecoq O. Lebel N, et al. Among authors: brevet p. Clin Exp Rheumatol. 2024 Aug;42(8):1536-1540. doi: 10.55563/clinexprheumatol/0znf7e. Epub 2024 Mar 13. Clin Exp Rheumatol. 2024. PMID: 38489323 Free article.
81 results